Telix Pharmaceuticals (TLPPF) Total Debt Growth (1y) (2024 - 2025)
Powered by 
Analysis
Telix Pharmaceuticals (TLPPF) Total Debt Growth (1y) (2024 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.49 Bn | 198.50 Bn | 7.24 Bn | 6.99% |
| 2 | Gilead Sciences | 180.93 Bn | 177.75 Bn | 6.22 Bn | 3.27% |
| 3 | Vertex Pharmaceuticals | 132.39 Bn | 124.53 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.17 Bn | 74.18 Bn | 3.93 Bn | 0.10% |
| 5 | Argenx Se | 61.05 Bn | 55.87 Bn | 1.37 Bn | - |
| 6 | Moderna | 55.19 Bn | 50.05 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.99 Bn | 30.68 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | 25.75% |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn | - |
| 10 | Telix Pharmaceuticals | 3.72 Bn | 3.43 Bn | - | - |